Azelis Group (AZE) Resumen de Acciones
Azelis Group NV se dedica a la distribución y venta de especialidades químicas e ingredientes alimentarios. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 2/6 |
| Salud financiera | 4/6 |
| Dividendos | 2/6 |
Recompensas
Análisis de riesgos
AZE Community Fair Values
Create NarrativeSee what 17 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Azelis Group NV
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | €10.36 |
| Máximo en las últimas 52 semanas | €15.48 |
| Mínimo de 52 semanas | €6.88 |
| Beta | 0.53 |
| Cambio en 1 mes | 0% |
| Variación en 3 meses | 16.67% |
| Cambio de 1 año | -28.06% |
| Variación en 3 años | -54.40% |
| Variación en 5 años | n/a |
| Variación desde la OPV | -63.00% |
Noticias y actualizaciones recientes
Actualización de narrativa • May 16
AZE: Dividend Support And Capital Actions Will Shape A More Constructive Outlook
The analyst price target for Azelis Group has shifted from about €17.35 to €16.00, reflecting updated assumptions on fair value and P/E, alongside recent mixed Street research where some analysts raised targets toward €10.50 to €12 and others trimmed targets to €15. Analyst Commentary Street research on Azelis Group is mixed but includes several clearly bullish signals on valuation and execution.
Actualización de narrativa • Apr 29
AZE: Governance Changes And Share Buybacks Will Pressure Premium P/E Expectations
Azelis Group's analyst price targets have shifted to a range between €10.50 and €15, reflecting updated views on fair value, discount rates, revenue growth and profit margins as analysts recalibrate expectations for the stock. Analyst Commentary Recent price target revisions for Azelis Group sit between €10.50 and €15, with some bearish analysts trimming expectations and others only making modest upward adjustments.Actualización de narrativa • Apr 15
AZE: Downgrades And Governance Changes Will Pressure Premium P/E Expectations
Analysts have nudged the fair value estimate for Azelis Group higher to €7.60 from €7.50, citing updated assumptions on revenue growth and discount rates, along with mixed changes in Street price targets that now range from €10.50 to €15. Analyst Commentary Recent research shows a split view on Azelis Group, with some Bearish analysts trimming expectations while others take a more neutral stance.Recent updates
Actualización de narrativa • May 16
AZE: Dividend Support And Capital Actions Will Shape A More Constructive Outlook
The analyst price target for Azelis Group has shifted from about €17.35 to €16.00, reflecting updated assumptions on fair value and P/E, alongside recent mixed Street research where some analysts raised targets toward €10.50 to €12 and others trimmed targets to €15. Analyst Commentary Street research on Azelis Group is mixed but includes several clearly bullish signals on valuation and execution.Actualización de narrativa • Apr 29
AZE: Governance Changes And Share Buybacks Will Pressure Premium P/E Expectations
Azelis Group's analyst price targets have shifted to a range between €10.50 and €15, reflecting updated views on fair value, discount rates, revenue growth and profit margins as analysts recalibrate expectations for the stock. Analyst Commentary Recent price target revisions for Azelis Group sit between €10.50 and €15, with some bearish analysts trimming expectations and others only making modest upward adjustments.Actualización de narrativa • Apr 15
AZE: Downgrades And Governance Changes Will Pressure Premium P/E Expectations
Analysts have nudged the fair value estimate for Azelis Group higher to €7.60 from €7.50, citing updated assumptions on revenue growth and discount rates, along with mixed changes in Street price targets that now range from €10.50 to €15. Analyst Commentary Recent research shows a split view on Azelis Group, with some Bearish analysts trimming expectations while others take a more neutral stance.Actualización de narrativa • Mar 31
AZE: Dividend Clarity And Refined Assumptions Will Support A More Constructive Outlook
The updated analyst price target for Azelis Group moves slightly lower to about €17.35 from roughly €17.70. Analysts point to refined assumptions on discount rates, revenue growth, profit margins and future P/E to support the change.Actualización de narrativa • Mar 17
AZE: Higher Dividend Visibility Will Support A More Constructive Outlook
The analyst price target for Azelis Group has been reduced from about €24.00 to roughly €17.70, as analysts factor in updated assumptions for discount rates, revenue growth, profit margins and future P/E, along with recent mixed Street research where some firms trimmed targets while others made only modest upward adjustments. Analyst Commentary Street research on Azelis Group has been mixed, but there are pockets of optimism that stand out in the recent updates.
Actualización de narrativa • Mar 03
AZE: Margin Recovery And Dividend Visibility Will Support Future Upside Potential
Azelis Group’s analyst fair value estimate has been trimmed from €13.20 to about €12.48. This reflects a reset in price targets after some analysts reduced their outlooks toward the mid-teens and low double digits, while still factoring in updated views on growth, margins and future P/E levels.Actualización de narrativa • Feb 17
AZE: Margin Recovery Will Support Upside Despite Recent Discounted Reset
Analysts have trimmed their price target for Azelis Group from about €14.27 to €13.20, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples following recent research, including the latest Kepler Cheuvreux downgrade. Analyst Commentary Recent research points to a more cautious stance on Azelis Group, with the latest price target reset to about €13.20.Actualización de narrativa • Feb 03
AZE: Downgrades And Sector Headwinds Will Pressure Premium P/E Expectations
Azelis Group’s analyst price target has shifted lower to about €7.50 from €10.00 as analysts factor in a higher discount rate, more cautious revenue growth assumptions, a lower future P/E multiple, and only a modest adjustment to profit margin expectations following recent downgrades. Analyst Commentary Bearish analysts are resetting expectations around Azelis Group, with several research notes pointing to a more cautious stance on the shares.Actualización de narrativa • Jan 20
AZE: Margin Recovery Is Expected To Support Re-Rating Despite Sector Caution
Narrative update Analysts have trimmed their price target for Azelis Group from about €15.71 to roughly €14.27, reflecting more cautious assumptions on growth, margins and future P/E following a series of rating and target cuts from European brokers. Analyst Commentary Recent research updates on Azelis Group have generally moved in a more cautious direction, with multiple firms lowering ratings and price targets.Actualización de narrativa • Jan 06
AZE: Fair View Balances Sector Headwinds With Prospects For 2025 Margin Recovery
We are lowering our Azelis Group fair value estimate to €10 from €16, reflecting analysts' reduced price targets and more cautious assumptions on growth, margins and sector conditions. Analyst Commentary Recent Street research on Azelis Group has turned more cautious, with several bearish analysts revising ratings and trimming price targets.Actualización de narrativa • Dec 22
AZE: Margins Are Expected To Recover As Industry Pressures Gradually Ease
The analyst price target for Azelis Group has been trimmed slightly to EUR 15.71 from EUR 15.82 as analysts factor in softer revenue growth and margins amid ongoing industry headwinds, partially offset by expectations for a gradual recovery and resilient valuation multiples. Analyst Commentary Analyst sentiment on Azelis Group has become more mixed, with a growing divergence between those who see the current downturn as an attractive entry point and those who expect industry headwinds to constrain performance for longer.Actualización de narrativa • Dec 08
AZE: Demand And Margins Will Recover From Current Cyclical Weakness
Azelis Group's analyst price target has been trimmed from about EUR 16.25 to approximately EUR 15.82, as analysts factor in sector wide pressure on European chemicals, more cautious views on diversified distributors, and expectations for only gradual recovery in growth and margins despite some supportive initiation coverage. Analyst Commentary Recent Street research on Azelis reflects a mixed backdrop, with several downward rating and target revisions offset by selective bullish initiation.Actualización de narrativa • Nov 24
AZE: Demand And Margins Will Rebound From Trough In 2025
Azelis Group’s analyst fair value target has been lowered from €17.39 to €16.25. Analysts point to ongoing industry headwinds and recent sector downgrades as key drivers of the more cautious outlook.Artículo de análisis • Nov 14
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking
It's not a stretch to say that Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 14x right now seems...Actualización de narrativa • Nov 07
AZE: Earnings Momentum Will Strengthen As Industry Conditions Improve In 2025
Azelis Group's analyst price target was revised downward by EUR 0.50 to EUR 17.39. This reflects analysts' expectations of slower revenue growth and persistent margin pressures in the near term.Actualización de narrativa • Oct 24
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
The analyst price target for Azelis Group has decreased from €18.50 to €17.89. This change reflects cautious sentiment among analysts amid industry headwinds and anticipated margin pressures through mid-2026.Actualización de narrativa • Oct 10
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Azelis Group's analyst price target has been reduced from €19.13 to €18.50. Analysts cite ongoing industry headwinds and reduced earnings forecasts as reasons for the cautious outlook.Artículo de análisis • Sep 30
Here's Why Azelis Group (EBR:AZE) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Actualización de narrativa • Sep 26
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Analysts have trimmed Azelis Group’s price target to €19.13, citing weaker Q2 earnings, a more conservative sector outlook, and increased market risk, partially offset by sustained strength in specialty testing. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.Actualización de narrativa • Sep 05
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Analysts have trimmed their earnings estimates and near-term growth outlook for Azelis Group amid sector challenges and softer fundamentals, resulting in a stable consensus price target of €19.56. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.Artículo de análisis • Jul 13
Azelis Group (EBR:AZE) Is Experiencing Growth In Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Artículo de análisis • Jun 17
Unpleasant Surprises Could Be In Store For Azelis Group NV's (EBR:AZE) Shares
Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 18.3x might make it look like a sell right now...Artículo de análisis • May 30
Azelis Group's (EBR:AZE) Dividend Will Be Increased To €0.161
Azelis Group NV ( EBR:AZE ) has announced that it will be increasing its dividend from last year's comparable payment...Artículo de análisis • May 27
An Intrinsic Calculation For Azelis Group NV (EBR:AZE) Suggests It's 39% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Azelis Group fair value estimate is €23.79 Azelis Group is...Artículo de análisis • May 09
Azelis Group's (EBR:AZE) Shareholders Will Receive A Bigger Dividend Than Last Year
Azelis Group NV ( EBR:AZE ) will increase its dividend from last year's comparable payment on the 1st of July to...Artículo de análisis • Apr 25
Azelis Group (EBR:AZE) Is Paying Out A Larger Dividend Than Last Year
Azelis Group NV ( EBR:AZE ) has announced that it will be increasing its dividend from last year's comparable payment...Artículo de análisis • Mar 28
Azelis Group (EBR:AZE) Shareholders Will Want The ROCE Trajectory To Continue
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Artículo de análisis • Mar 10
Azelis Group NV Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Azelis Group NV ( EBR:AZE ) came out with its annual results last week, and we wanted to see how the business is...
Nueva narrativa • Feb 23
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies.Artículo de análisis • Feb 23
Is Azelis Group (EBR:AZE) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Artículo de análisis • Jan 27
Are Investors Undervaluing Azelis Group NV (EBR:AZE) By 35%?
Key Insights Azelis Group's estimated fair value is €29.27 based on 2 Stage Free Cash Flow to Equity Current share...Artículo de análisis • Jan 06
Azelis Group NV's (EBR:AZE) Earnings Haven't Escaped The Attention Of Investors
When close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 12x, you may consider...Artículo de análisis • Nov 23
There's Been No Shortage Of Growth Recently For Azelis Group's (EBR:AZE) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Artículo de análisis • Oct 18
Azelis Group (EBR:AZE) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Sep 30
With Azelis Group NV (EBR:AZE) It Looks Like You'll Get What You Pay For
With a price-to-earnings (or "P/E") ratio of 28.8x Azelis Group NV ( EBR:AZE ) may be sending very bearish signals at...Artículo de análisis • Aug 24
Azelis Group NV's (EBR:AZE) Intrinsic Value Is Potentially 50% Above Its Share Price
Key Insights The projected fair value for Azelis Group is €27.87 based on 2 Stage Free Cash Flow to Equity Current...Artículo de análisis • Aug 04
Azelis Group NV Just Missed EPS By 28%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that Azelis Group NV ( EBR:AZE ) released its interim result to the market. The early...Artículo de análisis • Jul 26
We Like These Underlying Return On Capital Trends At Azelis Group (EBR:AZE)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...Artículo de análisis • Jun 14
Azelis Group (EBR:AZE) Will Pay A Smaller Dividend Than Last Year
Azelis Group NV's ( EBR:AZE ) dividend is being reduced from last year's payment covering the same period to €0.154 on...Artículo de análisis • Jun 09
Here's Why Azelis Group (EBR:AZE) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • May 22
Azelis Group's (EBR:AZE) Dividend Is Being Reduced To €0.154
Azelis Group NV's ( EBR:AZE ) dividend is being reduced from last year's payment covering the same period to €0.154 on...Artículo de análisis • Apr 22
Calculating The Intrinsic Value Of Azelis Group NV (EBR:AZE)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Azelis Group fair value estimate is €27.25 With €22.80 share...Artículo de análisis • Apr 04
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking
Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 24.8x might make it look like a strong sell right...Artículo de análisis • Mar 13
Azelis Group's (EBR:AZE) Dividend Will Be Reduced To €0.154
Azelis Group NV ( EBR:AZE ) is reducing its dividend from last year's comparable payment to €0.154 on the 2nd of July...Artículo de análisis • Jan 11
Azelis Group (EBR:AZE) Is Doing The Right Things To Multiply Its Share Price
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Rentabilidad de los accionistas
| AZE | BE Trade Distributors | Mercado BE | |
|---|---|---|---|
| 7D | -2.1% | 1.0% | 0.8% |
| 1Y | -28.1% | 1.0% | 19.6% |
Rentabilidad vs. Industria: Los resultados de AZE fueron inferiores a los de la industria Belgian Trade Distributors, que obtuvo un rendimiento del 1% el año pasado.
Rentabilidad vs. Mercado: AZE obtuvo unos resultados inferiores a los del mercado Belgian, que fueron del 19.6% el año pasado.
Volatilidad de los precios
| AZE volatility | |
|---|---|
| AZE Average Weekly Movement | 6.3% |
| Trade Distributors Industry Average Movement | 5.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BE Market | 6.8% |
| 10% least volatile stocks in BE Market | 2.7% |
Precio estable de las acciones: El precio de las acciones de AZE ha sido volátil durante los últimos 3 meses en comparación con el mercado Belgian.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AZE(6%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de Belgian.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 4,000 | Anna Bertona | www.azelis.com |
Azelis Group NV se dedica a la distribución y venta de especialidades químicas e ingredientes alimentarios. La empresa vende productos químicos especializados utilizados en las ciencias de la vida, como cuidado personal, cuidado del hogar, limpieza industrial, productos farmacéuticos, atención sanitaria, alimentación y nutrición, nutrición animal, sabores y fragancias, y soluciones medioambientales agrícolas; y en la industria química industrial, como CASE, materiales avanzados y aditivos, lubricantes, fluidos metalúrgicos, electrónica, productos químicos esenciales y finos, textiles, cuero y mercados de papel. Opera en Europa, Oriente Medio y África, así como en América y Asia-Pacífico.
Resumen de fundamentos de Azelis Group NV
| Estadísticas fundamentales de AZE | |
|---|---|
| Capitalización bursátil | €2.48b |
| Beneficios(TTM) | €111.19m |
| Ingresos (TTM) | €4.11b |
22.7x
Ratio precio-beneficio (PE)0.6x
Ratio precio-ventas (PS)¿Está AZE sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AZE | |
|---|---|
| Ingresos | €4.11b |
| Coste de los ingresos | €3.16b |
| Beneficio bruto | €946.75m |
| Otros gastos | €835.56m |
| Beneficios | €111.19m |
Últimos beneficios comunicados
Dec 31, 2025
Próxima fecha de beneficios
Jul 30, 2026
| Beneficios por acción (BPA) | 0.46 |
| Margen bruto | 23.03% |
| Margen de beneficio neto | 2.70% |
| Ratio deuda/patrimonio | 63.0% |
¿Cómo se ha desempeñado AZE a largo plazo?
Ver rendimiento histórico y comparativaDividendos
2.2%
Rentabilidad actual por dividendo49%
Ratio de pagos¿Paga AZE dividendos fiables?
Ver historial de dividendos e índices de referencia de AZE| fechas de dividendos de Azelis Group | |
|---|---|
| Fecha ex dividendo | Jun 29 2026 |
| Fecha de pago de dividendos | Jul 01 2026 |
| Días hasta ex dividendo | 38 days |
| Días hasta la fecha de pago de dividendos | 40 days |
¿Paga AZE dividendos fiables?
Ver historial de dividendos e índices de referencia de AZEAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 17:51 |
| Precio de las acciones al final del día | 2026/05/21 00:00 |
| Beneficios | 2025/12/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Azelis Group NV está cubierta por 21 analistas. 12 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Gaurav Jain | Barclays |
| James Stewart | Barclays |
| Anil Shenoy | Barclays |